MedPath

A prospective double-blind randomised controlled trial of the effect of a prebiotic mixture of bifidogenic oligosaccharides on enteral tolerance in preterm infants

Completed
Conditions
eonatal Diseases
Neonatal Diseases
Registration Number
ISRCTN72367147
Lead Sponsor
Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
4
Inclusion Criteria

1. Written informed parental consent
2. Preterm infants, appropriately grown for gestational age (Child Growth Foundation UK reference), with a gestational age of 32 weeks, whose mother agree to the use of formula if they are unable to or do not wish to breastfeed or are not able to provide sufficient breast milk

Exclusion Criteria

1. More than 72 hours exclusive parenteral nutrition
2. Immediately life-threatening congenital abnormality
3. Any condition requiring major surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath